Celltrion
068270.KS
#774
Rank
C$35.87 B
Marketcap
$173.22
Share price
1.34%
Change (1 day)
-3.84%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.04

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $4.17. In 2022 the company made an earnings per share (EPS) of $4.06 a decrease over its 2021 EPS that were of $4.83.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.04-0.67%
2022$4.06-15.84%
2021$4.8312.77%
2020$4.2870.79%
2019$2.5115.63%
2018$2.17-33.13%
2017$3.24141.17%
2016$1.348.28%
2015$1.2411.28%
2014$1.1216.37%
2013$0.96-67.42%
2012$2.9484.22%
2011$1.6062.13%
2010$0.9980.61%
2009$0.55-559.63%
2008-$0.12-123.16%
2007$0.51